In recent decades, advances in biomedical research have helped save or lengthen the lives of children around the world. With improved therapies, child and adolescent mortality rates have decreased significantly in the last half century. Despite these advances, pediatricians and others argue that children have not shared equally with adults in biomedical advances. Even though we want children to benefit from the dramatic and accelerating rate of progress in medical care that has been fueled by scientific research, we do not want to place children at risk of being harmed by participating in clinical studies. Ethical Conduct of Clinical Research Involving Children considers the necessities and challenges of this type of research and reviews the ethical and legal standards for conducting it. It also considers problems with the interpretation and application of these standards and conduct, concluding that while children should not be excluded from potentially beneficial clinical studies, some research that is ethically permissible for adults is not acceptable for children, who usually do not have the legal capacity or maturity to make informed decisions about research participation.The book looks at the need for appropriate pediatric expertise at all stages of the design, review, and conduct of a research project to effectively implement policies to protect children. It argues persuasively that a robust system for protecting human research participants in general is a necessary foundation for protecting child research participants in particular.
Marilyn J. Field and Richard E. Berman, Editors, Committee on Clinical Research Involving Children
1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 The Necessity and Challenges of Clinical Research Involving Children; 5 3 Regulatory Framework for Protecting Child Participants in Research; 6 4 Defining, Interpreting, and Applying Concepts of Risk and Benefit in Clinical Research Involving Children; 7 5 Understanding and Agreeing to Children's Participation in Clinical Research; 8 6 Payments Related to Children's Participation in Clinical Research; 9 7 Regulatory Compliance, Accreditation, and Quality Improvement; 10 8 Responsible Research Involving Children; 11 References; 12 Appendix A: Study Origins and Activities; 13 Appendix B: State Regulation of Medical Research with Children Adolescents: An Overview and Analysis; 14 Appendix C: Health Care Privacy and Conflict-of-Interest Regulations Relevant to Protection of Human Participants in Research; 15 Appendix D: Glossary, Acronyms, and Laws and Regulations; 16 Appendix E: Committee Biographical Statements; 17 Index
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Board on Health Sciences Policy, Committee on Palliative and End-of-Life Care for Children and Their Families, Richard E. Behrman, Marilyn J. Field
Institute of Medicine, Board on Health Sciences Policy, Committee on Understanding Premature Birth and Assuring Healthy Outcomes, Adrienne Stith Butler, Richard E. Behrman
Institute of Medicine, Board on Health Sciences Policy, and Practice Committee on Conflict of Interest in Medical Research, Education, Marilyn J. Field, Bernard Lo
Institute of Medicine, Board on Health Sciences Policy, Committee on Postmarket Surveillance of Pediatric Medical Devices, Hugh Tilson, Marilyn J. Field
Institute of Medicine, Board on Health Sciences Policy, Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA), Thomas F. Boat, Marilyn J. Field
Institute of Medicine, Board on Health Sciences Policy, Committee on Accelerating Rare Diseases Research and Orphan Product Development, Thomas F. Boat, Marilyn J. Field